Remodeling muscles with calcineurin

BioEssays

Volumn 22, Issue 6, 2000, Pages 510-519

  Olson, Eric N ^a   Williams, R Sanders ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 0034120259     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-1878(200006)22:6<510::AID-BIES4>3.0.CO;2-1     Document Type: Review

References (79)

1. Molkentin JD, Lu J, Antos CL, Markham B, Richardson J, Robbins J, Grant S, Olson EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998;93:215-228.
2. Sussman MA, Lim HW, Cambon N, Taigen T, Olson EN, Robbins J, Colbert MC, Wieczorek DF, Molkentin JD. Prevention of cardiac hypertrophy by calcineurin inhibition. Science 1998;281:1690-1693.
3. Musaro A, McCullagh KJ, Naya FJ, Olson EN, Rosenthal N. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATcl. Nature 1999;400:581-585.
4. 2+-dependent calcineurin signaling pathway. Nature 1999;400:576-581.
5. Chin ER, Olson EN, Richardson JA, Yang Q, Humphries C, Shelton JM, Wu H, Zhu W, Bassel-Duby R, Williams RS. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev 1998;12:2499-2509.
6. Dunn SE, Bums JL, Michel RN. Calcineurin is required for skeletal muscle hypertrophy. J Biol Chem 1999;274:21908-21912.
7. Abbott KL, Friday BB, Thaloor D, Murphy TJ, Pavlath GK. Activation and cellular localization of the cyclosporine A-sensitive transcription factor NF-AT in skeletal muscle cells. Mol Biol Cell 1998;9:2905-2916.
8. Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 1997;15:707-747.
9. 2+ calcineurin, and NF-AT. Cell 1999;96:611-614.
10. O'Keefe SJ, Tamura J, Kincaid RL, Tocci MJ, O'Neill EA, FK506-and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature 1992;357:692-694.
11. Flanagan WM, Corthesy B, Bram RJ, Crabtree GR. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 1991;352:803-807.
12. Liu J, Farmer JD Jr, Lane WS Fredman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991;66:807-815.
13. Lai MM, Burnett PE, Wolosker H, Blackshaw S, Snyder SH. Cain, a novel physiologic protein inhibitor of calcineurin. J Biol Chem 1998;273: 18325-18331.
14. Sun L, Youn H-D, Loh C, Stolow M, He W, Liu JO. Cabin1, a negative regulator for calcineurin signaling in T lymphocytes. Immunity 1998;8: 703-711.
15. Rothermel B, Vega RB, Yang J, Wu H, Bassel-Duby R, Williams RS. A protein encoded within the Down Syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J Biol Chem 2000 (in press).
16. Lopez-Rodriguez C, Aramburu J, Rakeman AS, Rao A. NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun. Proc Natl Acad Sci USA 1999;22:7214-7219.
17. Hoey T, Sun Y-L, Williamson K, Xu X. Isolation of two new members of the NF-AT gene family and functional characterization of the NF-AT proteins. Immunity 1995;2:461-472.
18. Beals CR, Sheridan CM, Turck CW, Gardner P, Crabtree GR. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 1997;275:1930-1933.
19. Chow CW, Rincon M, Cavanagh J, Dickens M, Davis RJ. Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway. Science 1997;278:1638-1641.
20. Zhu J, Shibasak F, Price R, Guillemot J-C, Yano, T, Dotsch V, Wagner G, Ferrara P, McKeon F. Intramolecular masking of nuclear import signal on NF-AT4 by casein kinase I and MEKK1. Cell 1998;93:851-861.
21. Liu S, Liu P, Borras A, Chatila T, Speck SH. Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member. EMBO J 1997;16:143-153.
22. Black B, Olson EN. .Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Ann Rev Cell Dev Biol 1998; 14:167-196.
23. Chien KR. Stress pathways and heart failure. Cell 1999;3:555-558.
24. McKinsey TA, Olson EN. Cardiac hypertrophy: sorting out the circuitry. Curr Opin Genet Dev 1999;9:267-274.
25. Hasegawa K, Lee SJ, Job, SM, Markham BE, Kitsis RN. Cis-acting sequences that mediate induction of the myosin heavy chain gene during left ventricular hypertrophy due to aortic constriction. Circ 1997; 96:3943-3953.
26. Herzig TC, Jobe SM, Aoki H, Molkentin JD, Cowley AW, Izumo S, Markham BE. Angiotensin II type 1a receptor gene expression in the heart: AP-1 and GATA4 mediate the response to pressure overload. Proc Natl Acad Sci USA 1997;94:7543-7548.
27. McCaffrey PG, Luo C, Kerpola TK, Jain J, Badalian TM, Ho AM, Burgeon E, Lane WS, Lambert JN, Curran T, Verdine GL, Rao A, Hogan PG. Isolation of the cyclosporin-sensitive T cell transcription factor NF-ATp. Science 1993a; 262:750-754.
28. Lim HW, Molkentin JD. Calcineurin and human heart failure. Nat Med 1999;5:246-247.
29. Tsao L, Neville C, Musaro A, McCullagh KJ-A, Rosenthal, N. Revisiting calceneurin and human heart failure. Nat Med 2000;6:2-3.
30. Seidman CE, Seidman SG. Molecular genetic studies of familial hypertrophic cardiomyopathy. Basic Res Cardiol 1998;93:13-16.
31. 2+, strong cross-bridge binding, and protein phosphorylation. J Biol Chem 1996; 271: 11611-1614.
32. Mende U, Kagen A, Cohen A, Aramburu, J, Schoen FJ, Neer EJ. Transient cardiac expression of consitutively active Gq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. Proc Natl Acad Sci USA 1998;95:13893-13898.
33. Olson EN, Molkentin JD. Prevention of cardiac hypertrophy by calcineurin inhibition: hope or hype? Circ Res 1999;84:623-632.
34. Sugden PH. Signaling in myocardial hypertrophy: life after calcineurin? Circ Res 1999;84:633-646.
35. Shimoyama M, Hayashi D, Takimoto E, Zou Y, OKa T, Uozumi H, Kudoh S, Shibasaki F, Yazaki Y, Nagai R, Komuro I. Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy. Circulation 1999;100:2449-2454.
36. Zhang W, Kowal RC., Rusnak F, Sikkink RA., Olson EN, Vatner S. Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats. Circ Res 1999;84:722-728.
37. Meguro T, Hong C, Asai, K, Takagi G, McKinsey TA., Olson EN, Victor R. Cyclosporine attenuates pressure overload hypertrophy in mice, while enhancing susceptibility to decompensated heart failure. Circ Res 1999; 84:735-740.
38. Muller JG, Nemoto S, Laser M, Carabello BA., Menick DR. Calcineurin inhibition and cardiac hypertrophy. Science 1998;282:1007a.
39. Luo Z, Shyu K-G, Gualberto A, Walsh K. Calcineurin inhibitors and cardiac hypertrophy. Nat Med 1998;4:1092-1093.
40. Ding B, Price RL, Borg TK, Weinberg EO, Halloran PF, Lorell BH. Pressure overload induces severe hypertrophy in mice treated with cyclosporine, an inhibitor of calcineurin. Circ Res 1999;84:729-734.
41. Chang RK, Alzona M, Alejos J, Jue K, McDiarmid SV. Marked left ventricular hypertrophy in children on tacrolimus (FK506) after orthotopic liver transplantation. Am J Cardiol 1998;81:1277-1280.
42. Wiesner RJ, Ehrnke J, Faulhaber R, Zak R, Ruegg JC. Dissociation of left ventricular hypertrophy, beta-myosin heavy chain gene expression, and myosin isoform switch in rats after ascending aortic stenosis. Circulation 1997;95:1253.
43. Goy J-J, Stauffer J-C, Deruaz J-P, Gillard D, Kaufmann U, Kuntzer T, Kappenberger L. Myopathy as possible side-effect of cyclosporin. Lancet 1989;1:1446-1447.
44. 2+ in isolated skeletal muscle. Proc Natl Acad Sci USA 1999;96:3281-3286.
45. 2+ channel gene expression. J Physiol 1999;516:331-341.
46. 2+ transient in ferret ventricular muscles during hypoxia and acidosis. Am J Physiol 1995;269:C690-C697.
47. Biring M S, Fournier M, Ross, D J, Lewis MI. Cellular adaptations of skeletal muscles to cyclosporine. J Appl Physiol 1998;84:1967-1975.
48. Chin ER, Olson EN, Richardson JA, Yang Q, Humphries C, Shelton JM, Wu H, Zhu W, Bassel-Duby R, Williams RS. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev 1998;12:2499-2509.
49. Goy JJ, Stauffer JC, Deruaz JP, Gillard D, Kaufmann U, Kuntzer T, Kappenberger L. Myopathy as possible side-effect of cyclosporin. Lancet 1989;1:1446-1447.
50. Hokanson JF, Mercier JG, Brooks GA. Cyclosporine A decreases rat skeletal muscle mitochondrial respiration in vitro. Am J Respir Crit Care Med 1995;151:1848-51.
51. Mercier JG, Hokanson JF, Brooks GA. Effects of cyclosporine A on skeletal muscle mitochondrial respiration and endurance time in rats. Am J Respir Crit Care Med 1995;151:1532-1536.
52. McPherron, AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997;387: 83-90.
53. DiMario JX, Fernyak SE, Stockdale FE. Myoblasts transferred to the limbs of embryos are committed to specific fibre fates. Nature 1993;362: 165-167.
54. Pette D, Vrbova G. Adaptation of mammalian skeletal muscle fibers to chronic electrical stimulation. Rev Physiol Biochem Pharmacol 1992;120: 115-202.
55. Yvbova G. The effect of motoneurone activity on the speed of contraction of striated muscle. J Physiol (Lond) 1963;169:513-526.
56. Williams RS, Salmons S, Newsholme EA, Kaufman RE, Mellor J. Regulation of nuclear and mitochondrial gene expression by contractile activity in skeletal muscle. J Biol Chem 1986;261:376-380.
57. Salmons S, Sreter FA. Significance of impulse activity in the transformation of skeletal muscle type. Nature 1976;263:30-34.
58. Fluck M, Carson JA, Goroon SE, Ziemiecki A, Booth FW. Focal adhesion proteins FAK and paxillin increase in hypertrophied skeletal muscle. Am J Physiol 1999;277:C152-162.
59. Seko Y, Takahashi, N, Tobe K, Kadowaki T, Yazaki Y. Pulsatile stretch activates mitogen-ctivated protein kinase (MAPK) family members and focal adhesion kinase (p125(FAK)) in cultured rat cardiac myocytes. Biochem Biophys Res Commun 1999;259:8-14.
60. Hutber CA, Hardie DG, Winder WW. Electrical stimulation inactivates muscle acetyl-CoA carboxylase and increases AMP-activated protein kinase. Am J Physiol 1997;272:E262-266.
61. Kemp BE, Mitchelhill KI, Stapleton D, Michell BJ, Chen ZP, Witters LA. Dealing with energy demand: the AMP-activated protein kinase. Trends Biochem Sci 1999;4:22-5.
62. 2+ concentration during constant 10 Hz stimulation of mouse single skeletal muscle fibres. Physiologist 1996;39:A-75.
63. Hennig R, Lomo T. Firing patterns of motor units in normal rats. Nature 1985;314:164-166.
64. Westerblad H, Allen DG. Changes in myoplasmic calcium concentration during fatigue in single muscle fibers. J Gen Physiol 1991;98:615-635.
65. Underwood LE, Williams RS. Pretranslational regulation of myoglobin gene expression. Am J Physiol 1987;252:C450-453.
66. Hickson RC, Rosenkoetter MA. Separate turnover of cytochrome c and myoglobin in the red types of skeletal muscle. Am J Physiol 1981;241: C140-144.
67. Spina RJ, Chi MM, Hopkins MG, Nemeth PM, Lowry OH, Holloszy JO. 1. Mitochondrial enzymes increase in muscle in response to 7-10 days of cycle exercise. J Appl Physiol 1996;80:2250-2254.
68. 2+ response amplitude and duration. Nature 1997;386:855-888.
69. Calvo S, Venepally P, Cheng J, Buonanno A. Fiber-type specific transcription of the Troponin I slow gene is regulated by multiple elements. Mol Cell Biol 1999;19:515-525.
70. Naya RJ, Mercer B, Shelton J, Richardson JA, Williams RS, Olson EN. Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo. J Biol Chem 2000;275:4545-4548.
71. Esser K, Nelson T Lupa-Kimball V, Blough E. The CACC box and myocyte enhancer factor-2 sites within the myosin light chain 2 slow promoter cooperate in regulating nerve-specific transcription in skeletal muscle. J Biol Chem 1999;274:12095-102.
72. Hughes SM, Koishi K, Rudnicki M, Maggs AM. MyoD protein is differentially accumulated in fast and slow skeletal muscle fibers and required for normal fibre type balance in rodents. Mech Dev 1997;61: 151-163.
73. O'Mahoney JV, Guven KL, Lin J, Joya JE, Robinson CS, Wade RP, Hardeman EC. Identification of a novel slow-muscle-fiber enhancer binding protein, MusTRD1. Mol Cell Biol 1998;18:6641-6652.
74. Mendoza I, Quintero FJ, Bressan RA, Hasegawa PM, Pardo JM. Activated calcineurin confers high tolerance to ion stress and alters the budding pattern and cell morphology of yeast cells. J Biol Chem 1996;271:23061-23067.
75. Matheos DP, Kingsbury TJ, Ahsan US, Cunningham KW. Tcn1p/Crz1p, a calcineurin-dependent transcription factor that differentially regulates gene expression in Saccharomyces cerevisiae. Genes Dev 1997;11: 3445-3458.
76. Stathopoulos AM, Cyert MS. Calcineurin acts through the CRZ1/TCN1-encoded transcription factor to regulate gene expression in yeast. Genes Dev 1997;11:3432-3444.
77. 2+ flux. Cell 1995;83: 463-472.
78. 2+ release channel closure in rat heart. J Physiol 1997;500:343-354.
79. Wu H, Naya JF, McKinsey T, Mercer B, Shelton J, Chin E, Simard AN, Michel R, Bassel-Duby R, Olson EN, Williams SR. MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type. EMBO J 2000: in press.